Syntegra Private Wealth Group LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,584 shares of the healthcare conglomerate's stock after selling 1,149 shares during the period. Syntegra Private Wealth Group LLC's holdings in UnitedHealth Group were worth $830,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Citizens National Bank Trust Department lifted its holdings in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $515,000. Full Sail Capital LLC lifted its holdings in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $39,413,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.
Analysts Set New Price Targets
UNH has been the topic of several research reports. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. KeyCorp cut their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $371.67.
Get Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Trading Up 1.3%
UNH opened at $240.94 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company's 50 day simple moving average is $295.77 and its two-hundred day simple moving average is $412.81. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $218.57 billion, a price-to-earnings ratio of 10.44, a price-to-earnings-growth ratio of 1.50 and a beta of 0.43.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the business earned $6.80 earnings per share. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.7%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report